Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Clin Rheumatol. 2023 Aug;42(8):2029-2035. doi: 10.1007/s10067-023-06598-5. Epub 2023 Apr 17.
To clarify the controversy between systemic lupus erythematosus (SLE) and thyroid disease, our study was designed to determine whether or not thyroid problems are associated with SLE.
We obtained the IEU GWAS database for summary information on genome-wide association studies (GWAS) of SLE and thyroid disease (hypothyroidism and hyperthyroidism) in people with European ancestry. Three approaches were employed to assess the causal link between SLE and thyroid disease: MR-Egger, weighted median (WM), and inverse variance weighted (IVW). The pleiotropy and heterogeneity were examined using a variety of techniques, including the MR-Egger intercept, the MR-PRESSO approach, and the Cochran's Q test.
MR analysis revealed a relationship between SLE and an elevated incidence of hypothyroidism (IVW OR: 1.004, 95% CI: [1.003, 1.005], P = 8.45E-16) and hyperthyroidism (IVW OR: 1.0009, 95% CI: [1.0005, 1.0010], P = 1.30E-5). Neither horizontal pleiotropy nor heterogeneity was detected in the sensitivity analysis.
Our MR study presents strong evidence demonstrating a link between SLE and an elevated risk of thyroid illness. This could help us learn more about what causes SLE and give people with SLE more thorough thyroid function tests and evaluations. Key points • We did not discover modest heterogeneity and pleiotropy in our study. •The findings of this study indicate that SLE is related to an elevated risk of hypothyroidism and hyperthyroidism.
为了澄清系统性红斑狼疮(SLE)和甲状腺疾病之间的争议,我们的研究旨在确定甲状腺问题是否与 SLE 有关。
我们从 IEU GWAS 数据库中获取了有关欧洲血统人群中 SLE 和甲状腺疾病(甲状腺功能减退症和甲状腺功能亢进症)的全基因组关联研究(GWAS)的汇总信息。采用三种方法评估 SLE 和甲状腺疾病之间的因果关系:MR-Egger、加权中位数(WM)和逆方差加权(IVW)。使用多种技术检查了 pleiotropy 和异质性,包括 MR-Egger 截距、MR-PRESSO 方法和 Cochran's Q 检验。
MR 分析显示,SLE 与甲状腺功能减退症(IVW OR:1.004,95% CI:[1.003,1.005],P=8.45E-16)和甲状腺功能亢进症(IVW OR:1.0009,95% CI:[1.0005,1.0010],P=1.30E-5)发生率升高之间存在关联。敏感性分析未发现水平 pleiotropy 或异质性。
我们的 MR 研究提供了强有力的证据,表明 SLE 与甲状腺疾病风险升高之间存在关联。这可以帮助我们更多地了解导致 SLE 的原因,并为患有 SLE 的人提供更全面的甲状腺功能检查和评估。
关键点
• 在我们的研究中,我们没有发现适度的异质性和 pleiotropy。
• 这项研究的结果表明,SLE 与甲状腺功能减退症和甲状腺功能亢进症的风险升高有关。